Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
20,42 USD | +5,77% | +3,53% | -25,30% |
15/04 | VERACYTE, INC. : Goldman Sachs optimiste sur le dossier | ZM |
26/02 | VERACYTE, INC. : Morgan Stanley conserve son opinion négative | ZM |
Métier
Nombre d'employés: 815
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Diagnostic Products and Biopharmaceutical Services
100,0
%
| 297 | 100,0 % | 361 | 100,0 % | +21,76% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
92,7
%
| 263 | 88,7 % | 335 | 92,7 % | +27,23% |
International
7,3
%
| 34 | 11,3 % | 27 | 7,3 % | -21,08% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 01/06/21 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 19/07/21 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/22 |
Phillip Febbo
CTO | Chief Tech/Sci/R&D Officer | 57 | 02/10/23 |
Richard T. Kloos
CTO | Chief Tech/Sci/R&D Officer | - | 05/04/12 |
Shayla Gorman
IRC | Investor Relations Contact | - | 01/02/22 |
Tracy Morris
IRO | Public Communications Contact | - | - |
John Leite
PRN | Corporate Officer/Principal | - | 01/09/22 |
Annie McGuire
HRO | Human Resources Officer | 44 | 28/02/22 |
Robert Brainin
PRN | Corporate Officer/Principal | 53 | 08/07/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 01/02/08 |
Robert Epstein
CHM | Chairman | 69 | 12/01/15 |
Karin Eastham
BRD | Director/Board Member | 74 | 01/12/12 |
John Bishop
BRD | Director/Board Member | 79 | 01/12/14 |
Jens Holstein
BRD | Director/Board Member | 60 | 01/08/20 |
Marc Stapley
CEO | Chief Executive Officer | 54 | 01/06/21 |
Eliav Barr
BRD | Director/Board Member | - | 09/08/22 |
Muna Bhanji
BRD | Director/Board Member | 61 | 19/03/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 78 436 369 | 77 537 934 ( 98,85 %) | 0 | 98,85 % |
Coordonnées société
Veracyte, Inc.
6000 Shoreline Court Suite 300
94080, South San Francisco
+650 243 6300
http://www.veracyte.comSecteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-25,30% | 1,48 Md | |
-19,84% | 10,82 Md | |
+48,03% | 3,25 Md | |
-32,87% | 2,11 Md | |
-14,15% | 2,08 Md | |
+18,85% | 1,02 Md | |
-2,62% | 733 M | |
-31,17% | 391 M | |
-43,68% | 383 M | |
+29,03% | 332 M |
- Bourse
- Actions
- Action VCYT
- Société Veracyte, Inc.